Unmet Needs and Device Therapies in HFrEF

5 views | 09 Aug 2023

CVRx | Barostim

56 videos

Barostim™ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.

Speakers

Jagmeet Singh

Jagmeet Singh is a professor of medicine at Harvard Medical School, Massachusetts General Hospital,Boston, MA, USA.

Start a conversation

Related Videos

HRS Symposium 2022 CVRx | Barostim

21 Jun 2022

The need for new device therapies in HFrEF CVRx | Barostim

21 Jun 2022

New Options for Heart Failure Patients with Narrow QRS CVRx | Barostim

10 Sep 2021

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure by Dr. R. Clement Darling and Dr. Manuel Perez-Izquierdo CVRx | Barostim

31 Aug 2023

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure by Dr. Manuel Perez-Izquierdo CVRx | Barostim

31 Aug 2023

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure by Dr. R. Clement Darling CVRx | Barostim

31 Aug 2023